Novomix 30



Indications and Reactions:

Role Indications Reactions
Primary
Type 2 Diabetes Mellitus 28.4%
Drug Use For Unknown Indication 16.9%
Product Used For Unknown Indication 13.0%
Diabetes Mellitus 11.5%
Type 1 Diabetes Mellitus 10.3%
Insulin-requiring Type 2 Diabetes Mellitus 5.0%
Hypertension 3.8%
Insulin-requiring Type Ii Diabetes Mellitus 2.7%
Atrial Fibrillation 1.5%
Gestational Diabetes 1.1%
Diabetes Mellitus Non-insulin-dependent 0.8%
Erythrodermic Psoriasis 0.8%
Gastrointestinal Disorder 0.8%
Insomnia 0.8%
Urinary Tract Infection 0.8%
Cardiac Failure 0.4%
Chronic Obstructive Pulmonary Disease 0.4%
Depression 0.4%
Diabetes Mellitus Insulin-dependent 0.4%
Hyperglycaemia 0.4%
Urinary Tract Infection 10.0%
Hypoglycaemia 8.3%
Pneumonia 8.3%
Respiration Abnormal 6.7%
Blood Glucose Increased 5.0%
Coronary Artery Disease 5.0%
Headache 5.0%
Hypothermia 5.0%
Incorrect Dose Administered 5.0%
Malaise 5.0%
Pulmonary Oedema 5.0%
Vomiting 5.0%
Cardiac Failure Chronic 3.3%
Convulsion 3.3%
Death 3.3%
Fall 3.3%
Generalised Erythema 3.3%
Hypoglycaemic Coma 3.3%
Hypoglycaemic Seizure 3.3%
Injection Site Pain 3.3%
Secondary
Diabetes Mellitus 18.0%
Type 2 Diabetes Mellitus 17.1%
Type 1 Diabetes Mellitus 16.6%
Diabetes Mellitus Insulin-dependent 8.3%
Drug Use For Unknown Indication 7.4%
Insulin-requiring Type 2 Diabetes Mellitus 6.5%
Product Used For Unknown Indication 5.5%
Gestational Diabetes 3.7%
Hypertension 3.7%
Erythrodermic Psoriasis 1.8%
Prophylaxis 1.8%
Thrombosis Prophylaxis 1.8%
Antiplatelet Therapy 1.4%
Blood Cholesterol Increased 1.4%
Insulin-requiring Type Ii Diabetes Mellitus 1.4%
Liver Disorder 1.4%
Sleep Disorder Therapy 1.4%
Hyperuricaemia 0.9%
Hypoglycaemia 12.0%
Influenza Like Illness 10.0%
Intentional Overdose 8.0%
Pneumonia 8.0%
Drug Resistance 6.0%
Tongue Oedema 6.0%
Urinary Tract Infection 6.0%
Diabetes Mellitus Inadequate Control 4.0%
Hypoglycaemic Coma 4.0%
Hypoglycaemic Seizure 4.0%
Injection Site Reaction 4.0%
Loss Of Consciousness 4.0%
Myocardial Infarction 4.0%
Premature Baby 4.0%
Renal Function Test Abnormal 4.0%
Weight Increased 4.0%
Blood Glucose Increased 2.0%
Blood Pressure Decreased 2.0%
Breast Cancer 2.0%
Dyspnoea 2.0%
Concomitant
Drug Use For Unknown Indication 29.5%
Product Used For Unknown Indication 21.6%
Hypertension 11.1%
Type 2 Diabetes Mellitus 9.3%
Diabetes Mellitus 7.3%
Rheumatoid Arthritis 3.5%
Hypercholesterolaemia 2.7%
Cardiomyopathy 1.9%
Chronic Lymphocytic Leukaemia 1.9%
Central Nervous System Lymphoma 1.6%
Type 1 Diabetes Mellitus 1.3%
Diabetes Mellitus Insulin-dependent 1.1%
Non-small Cell Lung Cancer 1.1%
Psoriatic Arthropathy 1.1%
Angina Pectoris 0.9%
Idiopathic Thrombocytopenic Purpura 0.9%
Asthma 0.8%
Blood Pressure 0.8%
Cardiac Failure Chronic 0.8%
Coronary Artery Disease 0.8%
Hypertension 8.6%
Pneumocystis Jiroveci Pneumonia 8.6%
Renal Failure 8.6%
Vitamin D Decreased 8.6%
Vomiting 8.6%
Squamous Cell Carcinoma 5.7%
Weight Decreased 5.7%
Blood Potassium Increased 4.3%
Nausea 4.3%
Renal Failure Acute 4.3%
Staphylococcal Infection 4.3%
Swelling 4.3%
Syncope 4.3%
Basal Cell Carcinoma 2.9%
Death 2.9%
Diabetic Ketoacidosis 2.9%
Hip Fracture 2.9%
Hyperkalaemia 2.9%
Hypoglycaemia 2.9%
Pancreatitis 2.9%
Interacting
Hypertension 21.4%
Multiple Sclerosis 21.4%
Diabetes Mellitus 14.3%
Type 2 Diabetes Mellitus 14.3%
Diabetes Insipidus 7.1%
Podagra 7.1%
Renal Failure 7.1%
Renal Failure Chronic 7.1%
Jaundice 50.0%
Renal Failure 50.0%